| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/25/2011 | US20110207664 Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins |
| 08/25/2011 | US20110207224 In vivo production of small interfering rnas that mediate gene silencing |
| 08/25/2011 | US20110206787 Morinda Citrifolia and Iridoid Based Formulations |
| 08/25/2011 | US20110206784 Composition for the prevention and treatment of postmenopausal syndrome containing extracts or fractions of aceriphyllum rossii as an effective ingredient |
| 08/25/2011 | US20110206768 Medical preparation |
| 08/25/2011 | US20110206766 Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation |
| 08/25/2011 | US20110206745 Octreotide implant having a release agent |
| 08/25/2011 | US20110206741 DHA Triglyceride Emulsions |
| 08/25/2011 | US20110206721 Fermented soy nutritional supplements including mushroom components |
| 08/25/2011 | US20110206696 Methods for inhibiting bone loss and bone metastasis |
| 08/25/2011 | US20110206687 Isolation And Purification Of Anti-IL-13 Antibodies Using Protein A Affinity Chromatography |
| 08/25/2011 | US20110206686 Il-23 antibodies |
| 08/25/2011 | US20110206678 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization |
| 08/25/2011 | US20110206677 Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 08/25/2011 | US20110206669 Mcp1 fusions |
| 08/25/2011 | US20110206664 Therapeutic agent for chronic arthritides diseases of childhood-related diseases |
| 08/25/2011 | US20110206648 Gene-enhanced tissue engineering |
| 08/25/2011 | US20110206634 Composite material for tissue repair |
| 08/25/2011 | US20110206622 Effervescent Compositions Comprising Phosphonates and Methods Related Thereto |
| 08/25/2011 | US20110206616 Recombinant derivatives of botulinum neurotoxins engineered for trafficking studies and neuronal delivery |
| 08/25/2011 | US20110206613 METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT |
| 08/25/2011 | DE102011009719A1 Agent useful e.g. for treating neurodermitis and diabetes mellitus comprises a fat phase including tocotrienols with lipids e.g. gamma -linolenic acid and an aqueous phase comprising e.g. palm fruit water, vitamin C, vitamin B2 and |
| 08/25/2011 | DE102010008982A1 Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie A silicon-containing biologically degradable material for anti-inflammatory therapy |
| 08/25/2011 | DE102010008981A1 Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie A silicon-containing biologically degradable material for pro-angiogenic therapy |
| 08/25/2011 | CA2790176A1 Triazolo [4, 5 - b] pyridin derivatives |
| 08/25/2011 | CA2789757A1 Aminothiazolones as estrogen related receptor-alpha modulators |
| 08/25/2011 | CA2789655A1 Bicyclic compounds and their uses as dual c-src / jak inhibitors |
| 08/24/2011 | EP2360254A1 Assays for screening anti-pd-1 antibodies and uses thereof |
| 08/24/2011 | EP2360252A1 Immunostimulatory nucleic acid molecules comprising GTCGTT motifs |
| 08/24/2011 | EP2360251A2 In vivo production of small interfering RNAs that mediate gene silencing |
| 08/24/2011 | EP2360184A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/24/2011 | EP2359855A2 Methods of administering anti-TNFalpha antibodies |
| 08/24/2011 | EP2359849A1 Combination therapy |
| 08/24/2011 | EP2359844A2 Medicaments and proteins based on TGF-beta monomers for the treatment of wounds |
| 08/24/2011 | EP2359831A2 Therapeutic applications of pro-apoptotic benzodiazepines |
| 08/24/2011 | EP2358438A1 Nutritional compositions with large lipid globule size |
| 08/24/2011 | EP2358373A1 Injectable polydeoxyribonucleotide composition for the treatment of osteoarticular diseases |
| 08/24/2011 | EP1951687B1 N-hydroxyamide derivatives and use thereof |
| 08/24/2011 | EP1594895B1 Growth factor complexes and modulation of cell migration and growth |
| 08/24/2011 | EP1499729B1 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
| 08/24/2011 | EP1485353B1 New inhibitors of histone deacetylase |
| 08/24/2011 | EP1480962B1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 08/24/2011 | EP1333833B1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases |
| 08/24/2011 | EP1259544B1 Heterologous polypeptide of the tnf family |
| 08/24/2011 | CN102165061A Modulation of TOLL-like receptor 9 expression by antisense oligonucleotides |
| 08/24/2011 | CN102164920A Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof as FAAH enzyme inhibitor |
| 08/24/2011 | CN102164908A Selective estrogen repector modulator for the treatment of osteoarthritis |
| 08/24/2011 | CN102164902A 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 08/24/2011 | CN102164606A Light-stabilized pharmaceutical composition |
| 08/24/2011 | CN102161984A Method for isolating tetramer uric acid oxydiazing enzyme |
| 08/24/2011 | CN102161690A Betulonic acid derivative for preparing medicine used for resisting osteoporosis as well as preparation method and application thereof |
| 08/24/2011 | CN102161653A Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof |
| 08/24/2011 | CN102161648A Preparation method and applications of isoflavone type compounds with selective estrogen receptor modulating activity |
| 08/24/2011 | CN102160883A Method for preparing medicine for treating sprain and contusion |
| 08/24/2011 | CN102160881A Chinese medicinal composition for treating femoral head necrosis |
| 08/24/2011 | CN102160880A Transdermal bone warming liquor |
| 08/24/2011 | CN102160731A Health care pillow prepared from traditional Chinese medicine and preparation method and applications thereof |
| 08/24/2011 | CN101843729B Chinese medicament for treating cervical spondylosis |
| 08/24/2011 | CN101843708B Chinese medicament for treating cervical spondylosis |
| 08/24/2011 | CN101816718B Method for producing traditional Chinese medicine composition for treating lumbocrural pain by utilizing micro-powder technology |
| 08/24/2011 | CN101711743B Febuxostat dry suspension and preparation method thereof |
| 08/24/2011 | CN101693022B Method for preparing resveratrol sustained-release capsule capable of preventing rheumatoid arthritis |
| 08/24/2011 | CN101690750B External medicine for curing hyperosteogeny |
| 08/24/2011 | CN101670068B Medicament for treating gonarthromeningitis and preparation technology thereof |
| 08/24/2011 | CN101628105B Medicine for treating lumbar vertebra and cervical vertebra diseases and preparation method thereof |
| 08/24/2011 | CN101574377B Effective part of sweetberry jointfir, preparation method and application thereof in preparing medicament for treating gout disease |
| 08/24/2011 | CN101543623B Green healthy bone-strengthening capsule |
| 08/24/2011 | CN101530470B Medicament for treating rheumatism and rheumatoid disease, and preparing method thereof |
| 08/24/2011 | CN101428051B Externally used medicament for treating bone fracture |
| 08/24/2011 | CN101375954B Medicament composition, preparation method thereof and use |
| 08/24/2011 | CN101102751B Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation |
| 08/23/2011 | US8003805 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 08/23/2011 | US8003791 Boronic ester and acid compounds, synthesis and uses |
| 08/23/2011 | US8003772 Chimeric PUFA polyketide synthase systems and uses thereof |
| 08/23/2011 | US8003628 Methods of inhibiting osteoclast activity |
| 08/23/2011 | US8003101 Inflammatory mediator antagonists |
| 08/23/2011 | CA2656535C Alkyne-substituted pyridone compounds and methods of use |
| 08/23/2011 | CA2492461C Fruit and/or vegetable derived composition |
| 08/23/2011 | CA2478186C Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 08/23/2011 | CA2462276C 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
| 08/23/2011 | CA2377209C Therapeutic peptide-based constructs |
| 08/18/2011 | WO2011100428A2 Compositions for improving bone mass |
| 08/18/2011 | WO2011100227A1 Benzylpyrrolidinone derivatives as modulators of chemokine receptor activity |
| 08/18/2011 | WO2011099942A1 New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy |
| 08/18/2011 | WO2011099832A2 Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same |
| 08/18/2011 | WO2011099576A1 Aptamer to fgf2 and use thereof |
| 08/18/2011 | WO2011098990A1 Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases |
| 08/18/2011 | WO2011098962A2 Anionic polysaccharides functionalised by at least two hydrophobic groups supported by an at least trivalent spacer |
| 08/18/2011 | WO2011098603A1 1,2,3-triazole-based peptidomimetic integrin inhibitors for the diagnosis and therapy of tumors |
| 08/18/2011 | WO2011098545A1 Novel 2-methyl-1,4-naphthoquinone derivatives and precursors thereof, having vitamin k activity |
| 08/18/2011 | WO2011047345A3 Methods of treating diseases of conditions using mesenchymal stem cells |
| 08/18/2011 | WO2011047277A3 Release of agents from cells |
| 08/18/2011 | US20110201691 Modulation of fibroblast activity |
| 08/18/2011 | US20110201676 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides |
| 08/18/2011 | US20110201655 Pharmaceutical composition improving intestinal absorption |
| 08/18/2011 | US20110201651 Mitotic kinesin inhibitors and methods of use thereof |
| 08/18/2011 | US20110201643 Novel n-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds |
| 08/18/2011 | US20110201641 Indole derivatives as crth2 receptor antagonists |
| 08/18/2011 | US20110201626 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase |
| 08/18/2011 | US20110201612 Compositions for Modulating a Kinase Cascade and Methods of Use Thereof |